SCHEMBL20152516

SCHEMBL20152516

CC(C)N(c1ccc2c(c1)C(C)(C)c1ccccc1-2)c1ccccc1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 5/20 0.35
ADRA2B P18089 2/20 0.31
CHRM3 P20309 2/20 0.31
HTR2C P28335 2/20 0.31
DRD3 P35462 2/20 0.31
MLNR O43193 1/20 0.31
NR1I2 O75469 1/20 0.31
CHRM2 P08172 1/20 0.31
ADRB1 P08588 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD2 P14416 1/20 0.31
ADRA2C P18825 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
HTR2A P28223 1/20 0.31
SLC6A4 P31645 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20199434 0.92 PDK2 (0.37) PDK2MEN1KMT2ALMNAMAPT
SCHEMBL20199431 0.91 PDK2 (0.39) PDK2MEN1KMT2ALMNAMAPT
SCHEMBL20152512 0.90 MEN1 (0.38) PDK2MEN1KMT2ALMNAMAPT
SCHEMBL13338607 0.86 PDK2 (0.38) PDK2ADRA2BCHRM3HTR2CDRD3
SCHEMBL13338356 0.86 PDK2 (0.41) PDK2ADRA2BCHRM3HTR2CDRD3
SCHEMBL13338606 0.85 PDK2 (0.35) PDK2ADRA2BCHRM3HTR2CDRD3
SCHEMBL24904950 0.85 PDK2 (0.39) PDK2ADRA2BCHRM3HTR2CDRD3
SCHEMBL13338387 0.85 PDK2 (0.42) PDK2ADRA2BCHRM3HTR2CDRD3
SCHEMBL13338605 0.84 PDK2 (0.38) PDK2ADRA2BCHRM3HTR2CDRD3
SCHEMBL16922876 0.83 PDK2 (0.38) PDK2ADRA2BCHRM3HTR2CDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-05-11 US disclosed
US-10714692-B2 Organic light emitting device having a carbazole-based compound formed between cathode and light emitting layer and a spirobifluorene-monoamine based compound formed between anode and light emitting layer LG CHEM, LTD. (KR) 2020-07-14 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed
US-20180138421-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714692-B2 Organic light emitting device having a carbazole-based compound formed between cathode and light emitting layer and a spirobifluorene-monoamine based compound formed between anode and light emitting layer COMT, MAOB, MAOA PDK2 227/4885ADRA2B 58/4885CHRM3 87/4885
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same DCX, TERT, TELO2 PDK2 484/4885ADRA2B 4464/4885CHRM3 4133/4885
US-20180138421-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY2, NR2E3, CRY1 PDK2 2455/4885ADRA2B 4082/4885CHRM3 3575/4885
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME DCX, TERT, TELO2 PDK2 484/4885ADRA2B 4464/4885CHRM3 4133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.